Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
December 12 2022 - 6:28AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF
FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR
15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of December 2022
Commission File Number: 001-39633
Abcam plc
(Translation
of registrants name into English)
Discovery
Drive
Cambridge Biomedical Campus
Cambridge, CB2 0AX
United Kingdom
(Address
of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form
20-F ☒ Form 40-F ☐
INFORMATION CONTAINED IN THIS REPORT ON FORM 6-K
On December 12, 2022, Abcam plc (the Company) issued a regulatory news service announcement in relation to its proposed cancellation
of the admission of the Companys Ordinary Shares to trading on AIM (the RNS Announcement). The RNS Announcement is furnished herewith as Exhibit 99.1 to this Report on Form 6-K.
EXHIBIT INDEX
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned, thereunto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
|
|
ABCAM PLC |
|
|
|
|
Date: December 12, 2022 |
|
|
|
By: |
|
/s/ Alan Hirzel |
|
|
|
|
|
|
Name: |
|
Alan Hirzel |
|
|
|
|
|
|
Title: |
|
Chief Executive Officer |
Abcam (CE) (USOTC:ABCZF)
Historical Stock Chart
From Jul 2024 to Jul 2024
Abcam (CE) (USOTC:ABCZF)
Historical Stock Chart
From Jul 2023 to Jul 2024